Literature DB >> 15200697

Social identity and worldview validation: the effects of ingroup identity primes and mortality salience on value endorsement.

Michael J Halloran1, Emiko S Kashima.   

Abstract

In this article, the authors report an investigation of the relationship between terror management and social identity processes by testing for the effects of social identity salience on worldview validation. Two studies, with distinct populations, were conducted to test the hypothesis that mortality salience would lead to worldview validation of values related to a salient social identity. In Study 1, reasonable support for this hypothesis was found with bicultural Aboriginal Australian participants (N = 97). It was found that thoughts of death led participants to validate ingroup and reject outgroup values depending on the social identity that had been made salient. In Study 2, when their student and Australian identities were primed, respectively, Anglo-Australian students (N = 119) validated values related to those identities, exclusively. The implications of the findings for identity-based worldview validation are discussed.

Entities:  

Mesh:

Year:  2004        PMID: 15200697     DOI: 10.1177/0146167204264080

Source DB:  PubMed          Journal:  Pers Soc Psychol Bull        ISSN: 0146-1672


  3 in total

1.  THE DEFENSIVE NATURE OF BENEFIT FINDING DURING ONGOING TERRORISM: AN EXAMINATION OF A NATIONAL SAMPLE OF ISRAELI JEWS.

Authors:  Brian J Hall; Stevan E Hobfoll; Daphna Canetti; Robert J Johnson; Sandro Galea
Journal:  J Soc Clin Psychol       Date:  2009-01-01

2.  Specific and Individuated Death Reflection Fosters Identity Integration.

Authors:  Laura E R Blackie; Philip J Cozzolino; Constantine Sedikides
Journal:  PLoS One       Date:  2016-05-06       Impact factor: 3.240

3.  First and second year medical students identify and self-stereotype more as doctors than as students: a questionnaire study.

Authors:  Bryan Burford; Harriet E S Rosenthal-Stott
Journal:  BMC Med Educ       Date:  2017-11-13       Impact factor: 2.463

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.